The forecasted mortality rate for bladder malignant neoplasms among males in the US is set to see a modest increase from 12.2 thousand in 2024 to 12.29 thousand by 2028, following a consistent upward trend. Compared to the data from 2023, the incremental rise stands at approximately 0.4% year-on-year, indicating a relatively stable yet slightly increasing trend.
Future trends to watch for include potential advancements in medical treatments which could alter these forecasts. Additionally, public health initiatives aimed at early detection and prevention might significantly impact these mortality projections, potentially stabilizing or even reducing the future rates.
